
Keywords: نکته; ED; early disease; AD; advanced disease; TERT; telomerase reverse transcriptase; TNF; α-tumor necrosis factor alpha; GRHL3; grainy head-like 3; ASCO; American Society of Clinical Oncology; MS; mass spectrometry; REMARK; Reporting Recommendations for Tumo